» Articles » PMID: 25362179

DBC1 is a Suppressor of B Cell Activation by Negatively Regulating Alternative NF-κB Transcriptional Activity

Overview
Journal J Immunol
Date 2014 Nov 2
PMID 25362179
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

CD40 and BAFFR signaling play important roles in B cell proliferation and Ig production. In this study, we found that B cells from mice with deletion of Dbc1 gene (Dbc1(-/-)) show elevated proliferation, and IgG1 and IgA production upon in vitro CD40 and BAFF, but not BCR and LPS stimulation, indicating that DBC1 inhibits CD40/BAFF-mediated B cell activation in a cell-intrinsic manner. Microarray analysis and chromatin immunoprecipitation experiments reveal that DBC1 inhibits B cell function by selectively suppressing the transcriptional activity of alternative NF-κB members RelB and p52 upon CD40 stimulation. As a result, when immunized with nitrophenylated-keyhole limpet hemocyanin, Dbc1(-/-) mice produce significantly increased levels of germinal center B cells, plasma cells, and Ag-specific Ig. Finally, loss of DBC1 in mice leads to higher susceptibility to experimental autoimmune myasthenia gravis. Our study identifies DBC1 as a novel regulator of B cell activation by suppressing the alternative NF-κB pathway.

Citing Articles

DBC1 maintains skeletal muscle integrity by enhancing myogenesis and preventing myofibre wasting.

Liang N, He J, Yan J, Han X, Zhang X, Niu Y J Cachexia Sarcopenia Muscle. 2023; 15(1):255-269.

PMID: 38062876 PMC: 10834312. DOI: 10.1002/jcsm.13398.


SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells.

Wang Y, Wang J, Xiao Y, Hu X, Zheng S, Fu J Aging (Albany NY). 2023; 15(17):8812-8832.

PMID: 37683133 PMC: 10522365. DOI: 10.18632/aging.205001.


T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship.

Petersone L, Edner N, Ovcinnikovs V, Heuts F, Ross E, Ntavli E Front Immunol. 2018; 9:1941.

PMID: 30210496 PMC: 6119692. DOI: 10.3389/fimmu.2018.01941.


Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers.

Fleischer L, Somaiya R, Miller G Front Pharmacol. 2018; 9:683.

PMID: 29997511 PMC: 6029583. DOI: 10.3389/fphar.2018.00683.


Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation.

Kong S, Dong H, Song J, Thiruppathi M, Prabhakar B, Qiu Q J Immunol. 2015; 195(8):3685-93.

PMID: 26378077 PMC: 4642440. DOI: 10.4049/jimmunol.1500713.

References
1.
Zou Y, Diamond B . Fate determination of mature autoreactive B cells. Adv Immunol. 2013; 118:1-36. DOI: 10.1016/B978-0-12-407708-9.00001-7. View

2.
Lin S, Wortis H, Stavnezer J . The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB/Rel proteins. Mol Cell Biol. 1998; 18(9):5523-32. PMC: 109137. DOI: 10.1128/MCB.18.9.5523. View

3.
Mackay F, Schneider P, Rennert P, Browning J . BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2002; 21:231-64. DOI: 10.1146/annurev.immunol.21.120601.141152. View

4.
Berberich I, Shu G, Clark E . Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol. 1994; 153(10):4357-66. View

5.
Chini C, Escande C, Nin V, Chini E . HDAC3 is negatively regulated by the nuclear protein DBC1. J Biol Chem. 2010; 285(52):40830-7. PMC: 3003384. DOI: 10.1074/jbc.M110.153270. View